Isoniazid is one of the most commonly used drugs to treat tuberculosis. Its administration is associated with a high incidence of hepatotoxicity. The aim of this study was to establish the protective effects of taurine against cytotoxicity induced by isoniazid and its suspected toxic metabolite hydrazine in isolated rat hepatocytes by measuring reactive oxygen species (ROS) formation, lipid peroxidation, mitochondrial depolarisation, reduced glutathione (GSH), and oxidised glutathione (GSSG). Isoniazid caused no signifi cant ROS formation in normal hepatocytes, but in glutathione-depleted cells it was considerable. Hydrazine caused ROS formation and lipid peroxidation in both intact and glutathione-depleted cells. Both isoniazid and hydrazine caused mitochondrial membrane depolarisation. Hydrazine lowered cellular GSH reserve and increased GSSG. Taurine ) effectively countered the toxic effects of isoniazid and/or hydrazine by decreasing ROS formation, lipid peroxidation, and mitochondrial damage. Taurine prevented depletion of GSH and lowered GSSG levels in hydrazine-treated cells. This study suggests that the protective effects of taurine against isoniazid and its intermediary metabolite hydrazine cytotoxicity in rat hepatocytes could be attributed to antioxidative action.
Tuberculosis is a serious infectious disease affecting large population segments, especially in developing countries (1) . Isoniazid is the most effective agent against tuberculosis and is used both for the treatment and the prophylaxis of this disease. Clinical use of isoniazid is associated with a high incidence of hepatotoxicity (2) . The exact mechanism by which isoniazid affects the liver is not clear yet, but some authors point to oxidative stress in hepatocytes (3) . The main culprit of hepatotoxic action, in fact, seems to be isoniazid metabolite hydrazine (4) . Hydrazine is the product of cytochrome P450 metabolising activity (5) and is believed to induce oxidative stress (6) . One of the consequences of oxidative stress is lipid peroxidation, as established in animal models treated with anti-tuberculosis drugs such as isoniazid (7) or hydrazine (8) . Another consequence, established by Chowdhury et al. (9) , is mitochondrial damage in hepatocytes.
Since oxidative stress is regarded as the major mechanism of isoniazid-induced hepatotoxicity, ROS scavengers or intracellular glutathione enhancers have been used to counteract isoniazid toxicity. One such agent, N-acetylcysteine (NAC) was reported to effectively inhibit isoniazid hepatotoxicity in rats (10) or rat hepatocytes (11) .
Taurine is a sulphur-containing amino acid that stabilises cell membrane and regulates cell ions, Ca 2+ in particular (12) . Moreover, hypotaurine, an intermediate in the biosynthesis of taurine, has been reported to scavenge free radicals in vivo (13) . There are several reports on the protective effects of taurine against hepatotoxicity induced by chemicals (14, 15) or xenobiotics (16, 17) . Its protective effects seem to extend to other types of cells as well (18, 19) , and have even been reported in clinical settings against diabetes (20) and pancreatitis (21) .
The aim of our study was to evaluate the in vitro effects of taurine against toxicity induced by isoniazid and its metabolite hydrazine in freshly isolated rat hepatocytes.
MATERIALS AND METHODS

Chemicals
Taurine, 4-(2-hydroxyethyl)-1-piperazineethanessulfonic acid (HEPES), triethanolamine, NAC, oxidised glutathione (GSSG), 1-bromoheptane (BHP), and 2-vinylpyridine were obtained from Acros (New Jersey, NJ, USA). Albumin bovine-type was purchased from Roche Diagnostics (Indianapolis, IN, USA). Rhodamine 123, isoniazid, 5,5'-dithio-bis(2-nitrobenzoic acid (DTNB), 2',7'-dichlorofl uorescindiacetate (DCFDA), hydrazine hydrate, and collagenase from Clostridium histolyticum were obtained from Sigma Aldrich (St. Louis, MO, USA). Ethyleneglycol-bis(ρ-aminoethyl-ether)-N,N,N',N'-tetra-acetic acid (EGTA), trichloroacetic acid (TCA), and Trypan blue were obtained from Merck (Darmstadt, Germany). Cimetidine was purchased from Medisca Pharmaceutique Inc. (Montreal, Canada). Thiobarbituric acid (TBA) was obtained from Serva (Heidelberg, Germany). All salts used for preparing buffer solutions were of analytical grade and obtained from Merck (Darmstadt, Germany).
Animals
Male Sprague-Dawley rats (weighing 250 g to 300 g) were obtained from the Tabriz University of Medical Sciences, Tabriz, Iran. The animals were fed standard chow diet and had free access to water. The animals were handled and used according to the animal handling protocol approved by the University's ethics committee.
Isolation and incubation of hepatocytes
Hepatocytes were isolated by collagenase perfusion, as described previously (22 (24) .
To establish whether taurine offers effective protection against drug-induced toxicity, it was added to the incubation medium at 200 μmol L -1 30 min before isoniazid or hydrazine.
Untreated hepatocytes were used as controls in all experiments. Hepatocytes treated with NAC (200 μmol L -1 ) were used as positive control, since its protective effects on isoniazid-induced hepatotoxicity have been proven in earlier studies (10) .
Cell viability
Hepatocyte viability was assessed by plasma membrane disruption as determined using the Trypan blue uptake test (24) . Cell viability was determined immediately after isolation and at scheduled time intervals following incubation. Approximately 85 % to 90 % of hepatocytes were viable at the time of isolation.
Determination of reactive oxygen species
Reactive oxygen species (ROS) was determined by measuring the fl uorescence intensity of DCFDA, as explained previously (25) . Briefl y, 1.6 μmol L -1 DCFDA was added to the incubation medium and 1 mL aliquots were drawn at different time points after incubation. These samples were centrifuged at 3000 g for 1 min. Fluorescence intensity was measured in supernatant using a Jasco ® FP-750 fluorescence spectrophotometer (Jasco Corporation, Tokyo, Japan). Excitation and emission wavelengths were 490 nm and 520 nm, respectively.
Determination of lipid peroxidation in hepatocytes
Hepatocyte lipid peroxidation was determined by measuring the amount of thiobarbituric acid reactive substances (TBARS) formed during the decomposition of lipid hydroperoxides. After treating a 1.0 mL aliquot of hepatocyte suspension (10 6 cells mL -1 ) with TCA (70 %) and boiling the supernatant with TBA (0.8 %) for 20 min, the absorbance of developed colour was measured at 532 nm in an Ultrospec2000 ® spectrophotometer (Pharmacia Biotech, Cambridge, England) (24) .
Mitochondrial membrane potential assay
Fluorescent dye rhodamine 123 accumulates in intact mitochondria by facilitated diffusion. When a mitochondrion is damaged and its membrane potential reduced, diffusion is no longer facilitated and the amount of rhodamine 123 in supernatant is increased. At different time points, we took 2 mL samples of cell suspension and centrifuged them at 1000 g for 1 min. The cell pellet was then resuspended in 2 mL of KrebsHenseleit buffer containing 1.5 μmol L -1 rhodamine 123, and gently shaken in a 37 °C water bath for 10 min. Hepatocytes were separated by centrifugation at 3000 g for 1 min, and the amount of rhodamine 123 appearing in the incubation medium was measured fl uorimetrically using a Jasco ® FP-750 fl uorescence spectrophotometer at 490 nm excitation and 520 nm emission wavelengths. The capacity of mitochondria to take up rhodamine 123 was calculated as the difference in fl uorescence intensity between control and treated cells (22) .
Determination of hepatocyte GSH/GSSG content
Hepatocyte GSH and GSSG content was determined using the enzymatic recycling method (26) . For GSH, we took 1 mL aliquots of cell suspension (10 6 cells), added 2 mL of 5 % TCA, and centrifuged. Then we added 0.5 mL of Ellman's reagent (0.0198 % DTNB in 1 % sodium citrate) and 3 mL of phosphate buffer (pH 8.0). The absorbance of developed colour was determined at 412 nm using an Ultrospec ® 2000 spectrophotometer. To assess hepatocyte GSSG level, cellular GSH content was fi rst covalently bonded to 2-vinylpyridine. Then the excess of 2-vinylpyridine was neutralised with triethanolamine, and GSSG reduced to GSH using glutathione reductase and NADPH. The amount of GSH formed was measured as described for GSH using the Ellman's reagent (0.0198 % DTNB in 1 % sodium citrate).
Statistical analysis
Results represent mean values [±standard error (SE)] of at least three independent experiments. Statistical signifi cance of difference between control and treatment groups was determined using the oneway analysis of variance (ANOVA) followed by a Tukey's post hoc test. Significance was set at P<0.05.
RESULTS
Isoniazid toxicity to rat hepatocytes was concentration-dependent ( Figure 1 ) and its LC 50 (causing death to 50 % of the cells after two hours of incubation) was 10 mmol L -1 ( Figure 1 ) . Cell death rate induced by concentrations lower than 5 mmol L -1 was not signifi cantly higher than control. Hydrazine was more cytotoxic than the parent drug and its LC 50 was 8 mmol L -1 ( Figure 2 ). In glutathione-depleted cells isoniazid and/or hydrazine-induced cell death rate was dramatically higher than in normal cells (Table 1) . N-acetylcysteine reduced this rate signifi cantly. In control hepatocytes, taurine and/or NAC attenuated the toxicity induced by isoniazid and/or hydrazine. However, in glutathionedepleted cells taurine showed no protective effect (data not shown).
Incubation with enzyme-inhibitory agents such as cimetidine reduced the rate of cell death induced by isoniazid ( Table 1 ). The effect of cimetidine on isoniazid-induced toxicity is in line with previous investigations in this fi eld (27) and might indicate the role of reactive metabolites such as hydrazine in isoniazid-induced hepatotoxicity.
There was no significant difference between isoniazid-treated and control hepatocytes in ROS formation levels (Figure 3 ), but when cellular glutathione reserves were depleted, a significant amount of ROS was formed (Figure 4) . Nacetylcysteine effectively reduced ROS formation in isoniazid-treated glutathione-depleted cells ( Figure  4 ). Hydrazine increased ROS formation in both normal and glutathione-depleted cells (Figures 3 and 4) . Pretreatment with taurine reduced ROS formation induced by hydrazine ( Figure 3 ) and so did NAC in normal or glutathione-depleted hepatocytes (Figure 3 ). 
05). b Signifi cantly lower than isoniazid-treated cells (P<0.05). c Signifi cantly higher than isoniazid-treated cells (P<0.05). d Signifi cantly lower than hydrazine-treated cells (P<0.05). e Signifi cantly higher than hydrazine-treated cells (P<0.05).
glutathione-depleted hepatocytes. Taurine reduced lipid peroxidation in hydrazine-treated cells, but had no signifi cant effect on lipid peroxidation caused by isoniazid and/or hydrazine in glutathione-depleted hepatocytes (data not shown). N-acetylcysteine treatment attenuated lipid peroxidation caused by hydrazine in both glutathione-depleted and normal hepatocytes. Since the cytotoxicity of isoniazid and its metabolite was more severe in glutathione-depleted hepatocytes, we measured cellular glutathione reserves to see if isoniazid or hydrazine affected cellular glutathione content. Our fi ndings confi rmed that they signifi cantly reduced cellular GSH ( Figure 6 ). Taurine in turn counteracted this reduction in cellular GSH to an extent.
The decrease in cellular GSH content was accompanied by an increase in GSSG in hydrazinetreated hepatocytes (Figure 7 ), indicating that GSH depletion was mainly due to its oxidation to GSSG. Treating rat hepatocytes with taurine signifi cantly reduced GSSG in hydrazine-treated cells. Isoniazid caused no signifi cant elevation in cellular GSSG content. Figure 8 shows changes in respect to mitochondrial membrane potential. Isoniazid and hydrazine caused mitochondrial depolarisation, and taurine and/or NAC counteracted their action in normal hepatocytes. As expected, in glutathione-depleted cells isoniazid/ hydrazine effects were even more damaging, and only NAC counteracted them signifi cantly.
DISCUSSION
Taurine showed no significant effect against isoniazid and/or hydrazine in glutathione-depleted cells. Aruoma et al. (13) have already suggested that taurine is a poor antioxidant and reacts slowly with reactive intermediates such as hydroxyl radical (OH   •   ) . This points to a limitation of our experiment, as may have not allowed suffi cient time for taurine to show better protective effects against chemicals-induced (such as isoniazid) toxicity as in other in vivo experimental models, such as the one described by Dinçer et al. (28) . Furthermore, some taurine precursors such as hypotaurine and cysteamine showed better radical scavenging and antioxidant properties (13) and may act better than taurine against chemical-induced cell injury in different situations.
In our study, the effects of isoniazid and hydrazine on ROS formation, lipid peroxidation, and mitochondrial depolarisation were dose-dependent and were even more pronounced in glutathionedepleted rat hepatocytes. However, taurine did protect normal rat liver cells against isoniazid and hydrazineinduced toxicity. These protective effects are associated with the scavenging of free radicals and prevention of GSH depletion (29, 30) , which might explain why it was not as effective in glutathione- ROS formation induced by hydrazine confi rmed earlier fi ndings (6) . To establish whether taurine could effi ciently counteract oxidative damage caused by isoniazid and hydrazine in rat hepatocytes, we compared its effects with the well-known cytoprotective agent N-acetylcysteine. Its protective effects on isoniazid-induced hepatotoxicity have been proven in earlier investigations (10) and generally they could be attributed to its direct effect in scavenging ROS (31) . The protective effects of taurine have been reported by Redmond et al. (32) , who found that it attenuates nitric oxide-and reactive oxygen intermediatedependent hepatocyte injury (32), while Kerai et al. (33) observed its protective properties against lipid peroxidation in rats poisoned with ethanol. The results of our study suggest that the protective effects of taurine against isoniazid and/or its metabolite might also be related to attenuation of oxidative stress in isolated rat hepatocytes.
Figure 3 Reactive oxygen species (ROS) formation induced by isoniazid and its metabolite in intact hepatocytes
The ability of hydrazine and isoniazid to produce ROS in GSH-depleted cells was further confi rmed by the measurements of TBARS, whose levels point to the increased amount of lipid peroxides. Our results suggest that taurine efficiently prevents lipid peroxidation induced both by isoniazid and its reactive metabolite. This is in line with earlier studies (17, 33) , which propose that taurine prevents lipid peroxidation through free-radical scavenging.
Another point that should be discussed is increased cellular glutathione content, which may reflect oxidative stress. We found that hydrazine (but not the parent compound isoniazid) increased cellular GSSG content in hepatocytes. Taurine lowered GSSG in hydrazine-treated cells, which could be attributed to its anti-oxidant properties. It is possible that lowered cellular glutathione content refl ects the conjugation of reactive metabolites with GSH or oxidation of GSH to GSSG (oxidised glutathione) (34) .
Greater mitochondrial damage caused by isoniazid and hydrazine in glutathione-depleted than in normal cells once again confi rms the importance of glutathione. What seems to be protecting functional proteins in mitochondria from reactive metabolites is GSH conjugation and therefore GSH depletion makes these targets more vulnerable.
Ozden et al. (35) have reported that the protective properties of taurine against chemical-induced toxicity effect are related to its effects on antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase. In our study, however, taurine did not show signifi cant protective effects in glutathione-depleted cells. Perhaps the reason was the insufficient time for taurine to upregulate antioxidant enzymes. In normal hepatocytes, taurine reduces oxidative stress by regulating cellular ions such as Ca 2+ , stabilising cellular membrane, and scavenging reactive species (36) , but in glutathionedepleted cells where cellular defence mechanisms are interrupted and isoniazid causes more dramatic toxic effect, this amino acid is unable to protect the hepatocytes. On the other hand, being a glutathione precursor and a more potent radical scavenger than taurine (37) , NAC has shown superior protective properties against isoniazid and hydrazine in both intact and glutathione-depleted cells.
CONCLUSION
Regardless of its shortcomings, our study suggests that taurine has a promising protective potential against drug-induced liver injury in rats, and we hope that future studies will address its potential use in more detail.
Sažetak
CITOPROTEKTIVNO DJELOVANJE TAURINA NA TOKSIČNOST IZONIAZIDA I HIDRAZINA U IZOLIRANIM STANICAMA ŠTAKORA Izoniazid je jedan od najčešćih lijekova za tuberkulozu, ali se njegova primjena povezuje s veoma učestalom hepatotoksičnosti. Cilj je ovog istraživanja bio ocijeniti djelotvornost taurina u zaštiti izoliranih hepatocita štakora od citotoksičnosti izazvane izoniazidom i njegovim toksičnim metabolitom hidrazinom. U tu smo svrhu utvrdili razine reaktivnih kisikovih spojeva (ROS), lipidnu peroksidaciju, depolarizaciju mitohondrija, reducirani glutation (GSH) te oksidirani glutation (GSSG). Izoniazid nije doveo do značajnoga nastanka ROS-a u normalnih hepatocita, ali je zato bio značajan u stanica osiromašenih glutationom. I izoniazid i hidrazine doveli su do depolarizacije membrane mitohondrija. Hidrazin je smanjio staničnu rezervu GSH i povećao razinu GSSG. Taurin (200 μmol L -1 ) i N-acetilcistein (200 μmol L -1 ) uspješno su zaštitili od toksičnoga djelovanja izoniazida i/ili hidrazina, smanjivši nastanak ROS-a, lipidnu peroksidaciju i oštećenje mitohondrija. Taurin je spriječio potpuni gubitak GSH-a te snizio razine GSSG-a u stanica tretiranih hidrazinom. Rezultati našeg istraživanje upućuju na to da se zaštitno djelovanje taurina od stanične toksičnosti izoniazida i hidrazina može pripisati njegovu andioksidacijskome djelovanju. 
